What happens to InMode device pricing if the company gets acquired?

Acquisition typically triggers changes to pricing, lease terms, and support structures as new owners optimize their business model. Practices should request written confirmation of pricing and service terms from any acquirer before a deal closes, as post-acquisition cost increases are common in device consolidation.

Will InMode Morpheus8 software support continue after acquisition?

Software support and training availability often change hands during device company acquisitions. Practices should proactively contact the acquirer to confirm ongoing support commitments, as new owners may consolidate support infrastructure or shift to different platforms.

Should I be concerned about InMode device consolidation as a practice owner?

Consolidation can create both risks and opportunities—pricing may increase, but new owners often expand installed bases and may offer upgrade incentives or better lease terms to retain customers. Monitor official communications from InMode and any acquirer, and document your current service agreements for negotiation leverage.

What aesthetic devices are most likely to be acquired next?

PE and strategic buyers continue targeting high-margin aesthetic device makers with strong cash flow and installed bases. Companies with proven platforms like radiofrequency, microneedling, and body contouring systems remain attractive acquisition targets in the consolidating market.

Can I negotiate better terms on my InMode lease during an acquisition?

Yes—acquisition creates a window for renegotiation as new owners seek to expand their installed base and retain customers. Practices should reach out to the acquirer's sales team early to discuss upgrade cycles, pricing adjustments, or improved service terms before post-close operations stabilize.

Monday, August 24, 2026 Never miss a recall or a rule change Go Pro · $20/mo →

RegulatoryAbbVie Launches Phase 2 Forehead Lines Studytoday MarketFacial Rejuvenation Market Forecast to Hit $5.66B by 20302 days ago Business & M&AAllergan Aesthetics Overhauls Loyalty Programtoday Devices & TechXERF Technology Enters Australian Market for Skin Tightening2 days ago Business & M&AEvolus Expands Estyme to Canada, Australia, New Zealandtoday MarketArm Fat Now Top Body Sculpting Concern in Singapore2 days ago Devices & TechSofwave Hits One Million Treatments Milestonetoday RegulatoryCKD Bio Pursues China Botox Approval—2027 Launch Targeted2 days ago RegulatoryRevance Wins FDA Nod for Under-Eye Injectablesyesterday MarketGLP-1 Pill Era Is Forcing Beauty Market Shiftyesterday InjectablesAEON Releases Expanded ABP-450 Botox Biosimilar Datayesterday Devices & TechUltherapy PRIME Real-Time Imaging Reshapes Midface Liftingyesterday

Business & M&A

InMode Receives Unsolicited Takeover Offer — Consolidation Pressure Mounts in Device Market

InMode shares rose on an unsolicited acquisition proposal, signaling continued PE and strategic interest in high-margin aesthetic device makers.

By Evan at Inside MedSpa · Jul 8, 2026

1-YEAR MOVE

INMD ▲1.0%

1-year price move by ticker
Ticker	Company	1-year change
INMD	InMode Ltd.	+1.0%

InMode disclosed an unsolicited takeover offer, sending its stock higher and reigniting discussion of consolidation in the aesthetic device market. The company, known for its Morpheus8 RF microneedling platform and radiofrequency body contouring devices, has been a consistent performer in the space.

Inside MedSpa Pro

You've reached your free articles this week.

Keep reading every article, unlock the full trackers, and get the twice-a-week intelligence brief — from $20/mo, or $200/yr (two months free). Never miss a recall or a rule change.

Every article, unlocked — no weekly limit
The full 50-state law tracker, stock & M&A watch
The twice-a-week, 2-minute intelligence brief
Recalls, FDA clearances & safety signals as they hit

See everything you get →

Cancel anytime, one click · 14-day money-back on annual

https://insidemedspa.com/article/inmode-unsolicited-takeover-offer-stock-rises/

Discussion

Free alerts

Get flagged before it costs you.

We'll flag the moment a recall or rule change hits your practice. One email a week, one click to leave.

Free · weekly · unsubscribe anytime. Privacy.

This morning's brief · 6 AM

The free version stops here.

What today's moves mean for your margins — and exactly what to do — already went out to Pro. By the time the trade press explains it, the window to act has closed.

Go Pro · $20/mo Two minutes a morning. Cancel anytime.

Live · Market movers

STRATA Skin Sciences-50%Hims & Hers Health+6.03%Estée Lauder+6.02%Bausch Health (Solta)-5.43%The Beauty Health Company (HydraFacial)+3.65%

The full stock & M&A watch →

FDA Activity — Aesthetic Devices

Monthly 510(k) clearances vs. recalls.

510(k) clearances Recalls

FDA Activity — Aesthetic Devices — Monthly 510(k) clearances vs. recalls.
Month	510(k) clearances	Recalls
Jun '25	0	4
Jul '25	0	1
Sep '25	0	1
Oct '25	0	2
Jan '26	0	1
Feb '26	0	5
Mar '26	0	5
Apr '26	0	19
May '26	7	18
Jun '26	34	8
Jul '26	23	4
Aug '26	5	0

The 50-state regulation tracker →

Inside MedSpa Pro

By the time it's news, it's too late.

The rebate cut, the scope-of-practice bill, the competitor opening down the street — it hits your business before the trade press ever covers it. Pro gets you there first: what happened, why it touches your margins, and exactly what to do — at 6 AM, in two minutes.

Go Pro · $20/mo Never miss a recall or a rule change. Cancel anytime.

The twice-a-week intelligence brief Go Pro · $20/mo →

InMode Receives Unsolicited Takeover Offer — Consolidation Pressure Mounts in Device Market

Share

Discussion

Leave a comment

By the time it's news, it's too late.